Skip to main content

Table 1 Clinical and demographic characteristics of participants

From: Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV+ patients on ART

Variable HIV- (n = 14) IR (n = 18) INR (n = 18) p value
Age, years, median (IQR) 33 (31.0–44.0) 39 (35.0–42.0) 44 (38.0–46.0) 0.089a
Male gender, N (%) 9 (64.3%) 13 (72.2%) 18 (100%) <  0.05b
BMI, kg/m2; median (IQR) 26.1 (25.1–27.7) 23.6 (21.7–26.9) 22.5 (20.8–24.6) <  0.01a
CD4+ T-cell count, cells/μL; median (IQR) 558.5 (492.0–705.0) 168 (141.0–256.0) <  0.001c
Nadir CD4+ T-cell count, cells/μL; median (IQR) - 69 (25–363.0) 42 (16.0–72.0) 0.055c
Nadir CD4+ T-cell count, cells/μL; mode - 58 14 <  0.01b
CD8+ T-cell count, cells/μL; median (IQR) 703.5 (619.0–950.0) 683.5 (588.0–1000.0) 0.899c
CD4+/CD8+ ratio; median (IQR) 0.8 (0.6–1.1) 0.21 (0.2–0.4) <  0.001c
Duration of HIV infection, years; median (IQR) 5.7 (3.3–10.0) 3.28 (1.1–6.9) 0.066c
Duration of ART, years; median (IQR) 5.5 (2.9–9.39) 2.8 (1.1–6.6) <  0.05c
  1. aKruskall-Wallis test with Bonferroni correction, bChi square; cMann-Whitney U test